News & Analysis
- Data & Tools
- Login | Register
Introduction Every company that spends money and resources on research, development and marketing for its products needs assurance that competitors (or other third parties) cannot take advantage of its innovation. Profiting from innovation…
23 October 2015
It has been said that the logo of the European Patent Office resembles the ideal method for drafting a set of patent claims: the broadest, most well-rounded claim should be in the centre, surrounded by additional layers of protection in the form of dependent claims. This can result in nested subject matter within the scope of the broadest claim. The result could be a set of nested claims – or could it?
14 October 2015
The latest edition of the Global Innovation Index (GII) was launched in London this week, offering a unique take on which global economies are ahead in ‘innovation-driven growth’. Put together by WIPO, INSEAD and Cornell University, the 400-page…
19 September 2015
As anyone whose family has been touched by the tragedy of suicide will tell you, it is a horrific experience to have to go though. Why, you constantly ask yourself. Shouldn’t we have noticed, could we have done more, was it something we did, were…
13 September 2015
The European Patent Convention hides a notorious concept known as ‘the inescapable trap’: if a granted claim involves added matter, there is no way to restore it except by shifting the scope of the patent – which in turn invalidates the patent. Recent European Patent Office practice suggests that there might be another way for patentees to shoot themselves in the foot: through ‘poisonous priority’.
02 September 2015
The General Court of the European Union recently confirmed that the trademarks SKY and SKYPE were confusingly similar. The decision is a setback for the popular Skype service, which allows users to call and chat over the Internet for free.
17 June 2015
Under Article 54(5) of the European Patent Convention (EPC) 2000, known substances or compositions are deemed to be novel if they are intended for specific use in a medical method and such use is not comprised in the state of the art (ie, second or…
17 June 2015
Stem cells have several applications with the potential for commercialisation. These range from unique services for customers (eg, a cell-based platform for drug cardiotoxicity testing for a pharmaceutical company) to a stem cell-based drug which is…
17 June 2015
After several days of rumours, it was confirmed yesterday that Singapore-incorporated electronics components manufacturer Avago Technologies has made an offer to acquire US semiconductor company Broadcom for $37 billion in what the Wall Street…
29 May 2015
Earlier this week, IAM reported on Philips' sale of the majority of its LED lighting unit Lumileds to a Chinese-led investment consortium. The deal - which is expected to complete during the third quarter of this year, subject to conditions and…
17 April 2015
Unlock unlimited access to all IAM content